Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

Serruys PW, Garcia-Garcia HM, Onuma Y.

Eur Heart J. 2012 Jan;33(1):16-25b. doi: 10.1093/eurheartj/ehr384. Epub 2011 Oct 31. No abstract available.

PMID:
22041548
2.

Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.

Yan J, Bhat VD.

EuroIntervention. 2009 Dec 15;5 Suppl F:F80-2. doi: 10.4244/EIJV5IFA13. Review. No abstract available.

PMID:
22100682
3.

Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.

Kraak RP, Grundeken MJ, Koch KT, de Winter RJ, Wykrzykowska JJ.

Expert Rev Med Devices. 2014 Sep;11(5):467-80. doi: 10.1586/17434440.2014.941812. Epub 2014 Aug 2. Review.

PMID:
25087771
4.

Design principles and performance of bioresorbable polymeric vascular scaffolds.

Oberhauser JP, Hossainy S, Rapoza RJ.

EuroIntervention. 2009 Dec 15;5 Suppl F:F15-22. doi: 10.4244/EIJV5IFA3. Review.

PMID:
22100671
5.

Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications.

Bourantas CV, Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW.

Int J Cardiol. 2013 Jul 15;167(1):11-21. doi: 10.1016/j.ijcard.2012.05.093. Epub 2012 Jun 28. Review.

PMID:
22748288
6.

A.R.T.: concept of a bioresorbable stent without drug elution.

Lafont A, Durand E.

EuroIntervention. 2009 Dec 15;5 Suppl F:F83-7. doi: 10.4244/EIJV5IFA14. Review. No abstract available.

PMID:
22100683
7.

Coronary stents: historical development, current status and future directions.

Iqbal J, Gunn J, Serruys PW.

Br Med Bull. 2013;106:193-211. doi: 10.1093/bmb/ldt009. Epub 2013 Mar 26. Review.

PMID:
23532779
8.

The bioabsorption process: tissue and cellular mechanisms and outcomes.

Vorpahl M, Finn AV, Nakano M, Virmani R.

EuroIntervention. 2009 Dec 15;5 Suppl F:F28-35. doi: 10.4244/EIJV5IFA5. Review. No abstract available.

PMID:
22100673
9.

Hybrid coronary revascularization: which patients? When? How?

Bonatti J, Lehr E, Vesely MR, Friedrich G, Bonaros N, Zimrin D.

Curr Opin Cardiol. 2010 Nov;25(6):568-74. doi: 10.1097/HCO.0b013e32833f02fb. Review.

PMID:
20885316
10.

Bioresorbable scaffolds: current evidence and ongoing clinical trials.

Bourantas CV, Zhang Y, Farooq V, Garcia-Garcia HM, Onuma Y, Serruys PW.

Curr Cardiol Rep. 2012 Oct;14(5):626-34. doi: 10.1007/s11886-012-0295-5. Review.

11.

Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.

Ielasi A, Tespili M.

Future Cardiol. 2014 May;10(3):409-20. doi: 10.2217/fca.14.14. Review.

PMID:
24976477
12.

Revascularization of left main coronary artery disease.

Lee MS, Faxon DP.

Cardiol Rev. 2011 Jul-Aug;19(4):177-83. doi: 10.1097/CRD.0b013e318219244d. Review.

PMID:
21646871
13.

Bioresorbable scaffold technologies.

Onuma Y, Ormiston J, Serruys PW.

Circ J. 2011;75(3):509-20. Epub 2011 Feb 3. Review.

14.

Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.

Diletti R, Tchetche D, Barbato E, Latib A, Farah B, van Geuns RJ, Colombo A, Fajadet J, van Mieghem NM.

Catheter Cardiovasc Interv. 2016 Sep;88(3):397-406. doi: 10.1002/ccd.26454. Epub 2016 May 3. Review.

PMID:
27143281
15.

Looking into the future with bioresorbable vascular scaffolds.

Costopoulos C, Naganuma T, Latib A, Colombo A.

Expert Rev Cardiovasc Ther. 2013 Oct;11(10):1407-16. doi: 10.1586/14779072.2013.839200. Review.

PMID:
24138526
16.

Absorbable stent: focus on clinical applications and benefits.

Gonzalo N, Macaya C.

Vasc Health Risk Manag. 2012;8:125-32. doi: 10.2147/VHRM.S22551. Epub 2012 Feb 29. Review.

17.

Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention.

Tenekecioglu E, Farooq V, Bourantas CV, Silva RC, Onuma Y, Yılmaz M, Serruys PW.

BMC Cardiovasc Disord. 2016 Feb 12;16:38. doi: 10.1186/s12872-016-0207-5. Review.

18.

Bioresorbable scaffolds: talking about a new interventional revolution [corrected].

Hassell ME, Grundeken MJ, Delewi R, Wykrzykowska JJ, Piek JJ.

Minerva Cardioangiol. 2013 Apr;61(2):165-79. Review. Erratum in: Minerva Cardioangiol. 2013 Jun;61(3):XVI. Woudstra P [removed].

PMID:
23492600
19.

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.

Yan TD, Padang R, Poh C, Cao C, Wilson MK, Bannon PG, Vallely MP.

J Thorac Cardiovasc Surg. 2011 May;141(5):1134-44. doi: 10.1016/j.jtcvs.2010.07.001. Epub 2010 Dec 17. Review.

20.

Approaches for prevention of restenosis.

Kraitzer A, Kloog Y, Zilberman M.

J Biomed Mater Res B Appl Biomater. 2008 May;85(2):583-603. Review.

PMID:
18098192

Supplemental Content

Support Center